Australia markets closed

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
115.97+0.27 (+0.23%)
At close: 04:00PM EDT
116.39 +0.42 (+0.36%)
Pre-market: 08:23AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 234.51B
Enterprise value 255.06B
Trailing P/E 23.72
Forward P/E 14.27
PEG ratio (5-yr expected) 4.20
Price/sales (ttm)4.90
Price/book (mrq)5.63
Enterprise value/revenue 5.22
Enterprise value/EBITDA 13.44

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 313.60%
S&P500 52-week change 329.75%
52-week high 3120.92
52-week low 392.19
50-day moving average 3113.81
200-day moving average 3104.39

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 31.19M
Shares outstanding 52.02B
Implied shares outstanding 62.03B
Float 81.93B
% held by insiders 10.00%
% held by institutions 16.94%
Shares short (30 Aug 2024) 45.7M
Short ratio (30 Aug 2024) 45.54
Short % of float (30 Aug 2024) 40.28%
Short % of shares outstanding (30 Aug 2024) 40.28%
Shares short (prior month 31 July 2024) 45.61M

Dividends & splits

Forward annual dividend rate 43.78
Forward annual dividend yield 43.26%
Trailing annual dividend rate 33.92
Trailing annual dividend yield 33.39%
5-year average dividend yield 43.61
Payout ratio 477.24%
Dividend date 319 Apr 2024
Ex-dividend date 407 Mar 2024
Last split factor 21116:1000
Last split date 309 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 33.11%
Operating margin (ttm)33.41%

Management effectiveness

Return on assets (ttm)8.86%
Return on equity (ttm)21.50%

Income statement

Revenue (ttm)48.86B
Revenue per share (ttm)23.87
Quarterly revenue growth (yoy)9.60%
Gross profit (ttm)N/A
EBITDA 19.3B
Net income avi to common (ttm)10.08B
Diluted EPS (ttm)4.89
Quarterly earnings growth (yoy)40.20%

Balance sheet

Total cash (mrq)8.43B
Total cash per share (mrq)4.16
Total debt (mrq)28.99B
Total debt/equity (mrq)69.18%
Current ratio (mrq)0.93
Book value per share (mrq)20.61

Cash flow statement

Operating cash flow (ttm)15.06B
Levered free cash flow (ttm)14.81B